HemoSonics Recognized as Top Medical Device Company in Triangle Business Journal's 2025 Life Sciences Awards Competition
HemoSonics' Blood Analyzer Revolutionizes OR Decision-Making
Here's the scoop: HemoSonics, a Durham-based medical device whiz focused on acute bleeding management, has won the Triangle Business Journal's 2025 Life Sciences Award for their Quantra Hemostasis System. This system is a game-changer in the viscoelastic testing scene, speeding up surgical decisions, enhancing patient outcomes, and slashing healthcare expenses by offering optimized coagulation data.
Now, you might be wondering why North Carolina is a hub for life sciences. Well, the state boasts 840 life sciences companies, with the Triangle region leading the charge. The Triangle Business Journal's Life Sciences Awards aim to recognize local bosses and research orgs making waves in the field, covering a wide spectrum from biotech to diagnostics.
So, what's the Quantra Hemostasis System all about? It consists of the Quantra Hemostasis Analyzer and QPlus and QStat Cartridges, which offer quick, comprehensive whole-blood coagulation analysis in less than 15 minutes. It's a lifesaver for clinicians, providing valuable data to inform patient-centered treatment decisions that improve care and optimize blood product usage. The technology behind it is SEER Sonorheometry, a proprietary ultrasound tech that measures the coagulation properties of a blood sample.
The system is FDA-cleared for use in cardiovascular surgery, trauma, liver transplantation, and significant orthopedic surgery. With minimal maintenance and user-friendly operation, it empowers hospitals to launch a standardized, efficient viscoelastic testing program.
Bob Roda, HemoSonics CEO, couldn't be more thrilled to be in Durham, a city known for its pioneering biotech and medical tech advancements. The company has been honored for the Quantra System with awards like the 2024 TIME Best Inventions, 2024 Fast Company Most Innovative Companies (Medtech), 2024 Edison Awards (Point-of-Care and Therapeutic Solutions), and the 2024 Deloitte Fast 500.
To learn more about HemoSonics and the Quantra Hemostasis System, visit HemoSonics.com. If you're a journalist needing more info, feel free to reach out to Mindy Hull or Michael Held-Hernandez at [email protected]. They're with Mercury Global Partners, HemoSonics' PR peeps.
Sources:- North Carolina Biotechnology Center- HemoSonics press releases- Vizient award announcement
- In the world of finance and business, HemoSonics, a North Carolina-based medical tech company, has seen significant success with their Quantra Hemostasis System, which has been recognized with multiple prestigious awards.
- The Quantra Hemostasis System, a groundbreaking tool in health and wellness, particularly medical-conditions, offers rapid, comprehensive blood coagulation analysis, capable of improving patient outcomes, optimizing blood product usage, and contributing to cost savings in surgical procedures.
- The Triangle Business Journal's Life Sciences Awards, which highlight achievements in various fields, such as biotech, diagnostics, and more, have honored HemoSonics for their contribution to science, specifically the Quantra Hemostasis System, which has revolutionized OR decision-making.
